Table 4.
Ref. no. and year of publ. | No. of patients | Methods | Outcome | Conclusion |
---|---|---|---|---|
(5) 2008 | One female | Spirometry, biochemistry, X-ray, CT scan, open lung biopsy, initiation of ERT | Mixed restrictive/obstructive pattern, patchy ground-glass infiltrations, peribronchiolar fibrosis, and smooth-muscle cell hyperplasia. Inclusion bodies. ERT stabilised the airway obstruction | Pulmonary involvement is due to lysosomal storage on cells. Treatment with ERT was able to stabilise the airway obstruction |
(8) 2007 | One female | Biochemistry, spirometry, ventilation-perfusion scan, echocardiography, CT scan. Initiation of ERT | LVH, reduced diffusion capacity, a combination of ground-glass infiltrations and air trapping. Improvement of pulmonary signs but persisting opacities and air trapping after ERT | ERT might improve pulmonary signs but has no effect on ground-glass infiltrations and air trapping found on CT scan |
(18) 2013 | One female | Spirometry, renal biopsy, lung biopsy, biochemistry, electron microscopy | Patient with the diagnosis of COPD received a lung transplant. Later, Fabry disease was diagnosed | Rare differential diagnosis might be hidden under more common diseases. Respiratory impairment cannot be denied |
All studies included physical examination and interview about past medical history.
ERT, enzyme replacement therapy; LVH, left ventricular hypertrophy; COPD, chronic obstructive pulmonary disease.